https://www.selleckchem.com/pr....oducts/cdk2-inhibito
A small shift in high-sensitivity cardiac troponin T (hs-cTnT) assays can lead to different result interpretation and consequent patient management. We explored whether a small bias could be detected using conventional internal quality control (QC) procedures, evaluated the performance of moving average (MA)-based QC procedures, and proposed a new QC procedure based on the moving rate (MR) of positive patient results of hs-cTnT assays. The ability of conventional QC to detect a 5 ng/L bias was examined using the13s/ 22s/R4s mu
Aimer
Commentaire
Partagez
